Huawei and Qualcomm Sign a Broad Patent License, and Qualcomm Buys Some of Huawei’s US Patents

Huawei and Qualcomm have agreed a multi-year patent license covering both companies’ portfolios across 5G, compute, AI and networking, with Qualcomm also buying certain Huawei US patents in compute, AI and networking. The deal closes once the necessary regulatory approvals are in place, and both sides frame it around licensing consistent with fair, reasonable and non-discriminatory principles.

The unusual element is the direction of the patent sale. Qualcomm is the company buying Huawei’s US patents, not the other way around. That reads as a move to clear freedom-to-operate questions in the US market, where Huawei’s patent position has been a standing issue for American vendors. For Huawei, selling US patents while licensing the rest of the portfolio is a way to monetize intellectual property that has been hard to enforce in the US, and to keep a revenue line open from a market it cannot sell equipment into.

The FRAND reference is doing quiet work in the announcement. Both companies invoke it, which matters because the contested ground of 5G standard-essential patents has been fought over for years: what counts as fair and reasonable, and whether portfolio-wide cross-licenses are the right structure at all. The public IPR database maintained by the European standards body, which the regulatory authority and courts treat as the authoritative record of declared 5G standard-essential patents, holds more than 60,000 declarations across dozens of companies, which is the scale at which bilateral disputes multiply. A broad cross-license between two of the largest patent holders in 5G reduces the number of enforcement actions both sides need to run, and it removes a source of uncertainty for their respective customers.

What the announcement does not say is as telling as what it does. No financial terms, no duration beyond “multi-year,” no list of which patents change hands, and no indication of whether the deal affects any pending litigation between the two. The transaction is also conditional on regulatory approval, which for a deal involving a Chinese vendor and US patents is not a formality.

For the industry, the practical effect is on licensing cost predictability. When two large patent holders settle on a portfolio basis, the downstream cost of 5G, compute and AI components becomes easier to model for device makers and network vendors, because one more bilateral dispute is off the table. Whether that predictability reaches end buyers depends on whether either side passes the saving through.

Supplier’s note: We track 5G patent licensing cost as a line item in our BOM reviews, and we can share a short note on which Qualcomm baseband and modem families carry the broadest patent coverage for customers building 5G CPE or industrial gateways. Lead time on Qualcomm-based modules from our Shenzhen stock is four to six weeks, and we hold buffer stock of the Snapdragon X75 and X72 modem families for customers whose builds need cellular connectivity without a separate patent royalty negotiation. For customers pricing a 5G device who want the licensing exposure mapped against the component cost, send us your target chipset and volume and we will come back with a component-level breakdown. We have done this mapping for more than a dozen CPE and gateway designs in the last year, and the licensing line is usually the one that moves the final price.